Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers

Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers

US Patent 11179370 · Granted Nov 23, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ultra short acting anti-arrhythmic agents2025
Ultra short acting anti-arrhythmic agents2023
Ultra short acting anti-arrhythmic agents2022
Ultra short acting anti-arrhythmic agents2020
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic 2020
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic 2020
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic 2018
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic 2018
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic 2016
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic 2016
Cannabinoid receptor antagonists/inverse agonists useful for treating disease co2015
Cannabinoid receptor antagonists/inverse agonists useful for treating disease co2015